1. Home
  2. TPVG vs BNTC Comparison

TPVG vs BNTC Comparison

Compare TPVG & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriplePoint Venture Growth BDC Corp.

TPVG

TriplePoint Venture Growth BDC Corp.

HOLD

Current Price

$6.60

Market Cap

254.1M

ML Signal

HOLD

Logo Benitec Biopharma Inc.

BNTC

Benitec Biopharma Inc.

HOLD

Current Price

$12.01

Market Cap

405.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TPVG
BNTC
Founded
2013
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
254.1M
405.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TPVG
BNTC
Price
$6.60
$12.01
Analyst Decision
Hold
Strong Buy
Analyst Count
6
3
Target Price
$6.38
$27.67
AVG Volume (30 Days)
480.0K
224.2K
Earning Date
11-05-2025
02-13-2026
Dividend Yield
13.84%
N/A
EPS Growth
208.85
N/A
EPS
0.84
N/A
Revenue
$93,623,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$7.50
N/A
P/E Ratio
$7.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.24
$9.70
52 Week High
$8.20
$17.15

Technical Indicators

Market Signals
Indicator
TPVG
BNTC
Relative Strength Index (RSI) 61.45 42.71
Support Level $6.02 $10.99
Resistance Level $6.75 $14.39
Average True Range (ATR) 0.16 1.10
MACD 0.02 0.01
Stochastic Oscillator 82.88 44.51

Price Performance

Historical Comparison
TPVG
BNTC

About TPVG TriplePoint Venture Growth BDC Corp.

TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

Share on Social Networks: